Video

Identifying The Biggest Opportunities For Radiopharmaceuticals

Source: Life Science Leader

In this segment from the Life Science Leader Live event “Overcoming Operational Challenges And New Opportunities,” Richard Valeix, CEO at Telix Therapeutics, talks about the similarities between radiopharmaceuticals and immuno-oncology therapies, and the potential for new combination therapies. Richard also predicts that radiopharmaceuticals will also move into earlier lines of therapy, beyond treating neuroendocrine and prostate cancers. 

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: